-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Sp47g68pEg9VozJsdckDwAfjeUAu70CN83BH/E5/VSR9kFIkDVhKc+qkvNNtGCAs A6DczBr5efx8UJUYEvaguQ== 0000898432-09-001182.txt : 20090923 0000898432-09-001182.hdr.sgml : 20090923 20090923155548 ACCESSION NUMBER: 0000898432-09-001182 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090923 DATE AS OF CHANGE: 20090923 EFFECTIVENESS DATE: 20090923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Knopp NeuroSciences Inc CENTRAL INDEX KEY: 0001347819 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-84369 FILM NUMBER: 091082750 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY DR STE 400 CITY: PITTSBURGH STATE: PA ZIP: 15219 BUSINESS PHONE: 412-488-1776 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY DR STE 400 CITY: PITTSBURGH STATE: PA ZIP: 15219 D 1 primary_doc.xml X0502 D LIVE 0001347819 Knopp NeuroSciences Inc 2100 Wharton Street Suite 615 Pittsburgh PA 15203 412-488-1776 Knopp Neurosciences Merger Sub, Inc. DELAWARE Corporation true 2006 Michael E. Bozik 2100 Wharton Street Suite 615 Pittsburgh PA 15203 Director Executive Officer Promoter Gregory T. Hebrank 2100 Wharton Street Suite 615 Pittsburgh PA 15203 Director Executive Officer Promoter Thomas, Jr. Petzinger 2100 Wharton Street Suite 615 Pittsburgh PA 15203 Director Executive Officer Promoter Evan Ingersoll 2100 Wharton Street Suite 615 Pittsburgh PA 15203 Executive Officer Valentin K. Gribkoff 2100 Wharton Street Suite 615 Pittsburgh PA 15203 Executive Officer Jeffrey S. McCormick Saturn Management LLC 75 Federal Street Boston MA 02110 Director Biotechnology Decline to Disclose 06 false 2009-09-21 false true true false 0 Saturn Capital, Inc. 15412 None None Saturn Capital, Inc. 75 Federal Street Boston MA 02110 CA CT MA NE NJ NY NC OH PA TN VA 12500001 23257 12476744 Offering amount includes exercise of warrant to purchase stock. Such warrant will be issued only to placement agent. false 2 800000 true 0 true Estimated amount assumes successful sale of whole offering amount; placement agent may also be issued warrant to purchase up to 1,315,790 Series B Preferred Stock at a price of $1.90 per share. 0 false Knopp Neurosciences Inc. /s/ Michael E. Bozik Michael E. Bozik President and Chief Executive Officer 2009-09-23 -----END PRIVACY-ENHANCED MESSAGE-----